Venture Visionary Partners LLC Increases Stock Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Venture Visionary Partners LLC increased its stake in Intuitive Surgical, Inc. by 27.9%, owning 4,526 shares worth approximately $2.46 million as of its latest SEC filing.
• Insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical, representing a 59.69% decrease in his holdings, while additional executives have also significantly reduced their stakes.
• Despite some analysts lowering ratings, Intuitive Surgical still holds an average price target of $595.95 with 13 analysts rating it as a Buy, reflecting moderate optimism about the stock's future performance.

Venture Visionary Partners LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 27.9% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 4,526 shares of the medical equipment provider's stock after buying an additional 987 shares during the quarter. Venture Visionary Partners LLC's holdings in Intuitive Surgical were worth $2,459,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of ISRG. Brighton Jones LLC raised its holdings in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after buying an additional 731 shares during the period. Rothschild Investment LLC raised its holdings in shares of Intuitive Surgical by 16.6% during the 1st quarter. Rothschild Investment LLC now owns 561 shares of the medical equipment provider's stock valued at $278,000 after buying an additional 80 shares during the period. American National Bank & Trust raised its holdings in shares of Intuitive Surgical by 19.6% during the 1st quarter. American National Bank & Trust now owns 293 shares of the medical equipment provider's stock valued at $145,000 after buying an additional 48 shares during the period. Baker Tilly Wealth Management LLC grew its stake in Intuitive Surgical by 6.8% during the 1st quarter. Baker Tilly Wealth Management LLC now owns 1,340 shares of the medical equipment provider's stock valued at $664,000 after purchasing an additional 85 shares in the last quarter. Finally, Fiduciary Alliance LLC grew its stake in Intuitive Surgical by 11.3% during the 1st quarter. Fiduciary Alliance LLC now owns 13,907 shares of the medical equipment provider's stock valued at $6,888,000 after purchasing an additional 1,410 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of the business's stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares in the company, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company's stock, valued at $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 in the last 90 days. 0.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ISRG. Wall Street Zen lowered Intuitive Surgical from a "buy" rating to a "hold" rating in a research note on Friday. Wells Fargo & Company raised their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research note on Wednesday, July 23rd. Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Royal Bank Of Canada restated an "outperform" rating and set a $615.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Finally, Truist Financial raised their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research note on Wednesday, July 23rd. Thirteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $595.95.

Intuitive Surgical Trading Down 0.4%

Shares of ISRG opened at $439.22 on Tuesday. The firm has a market cap of $157.45 billion, a price-to-earnings ratio of 61.26, a PEG ratio of 4.62 and a beta of 1.61. The stock has a 50 day moving average of $467.89 and a 200-day moving average of $501.35. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business's revenue was up 21.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.78 EPS. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.